Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

School and Family-Based Obesity Prevention in Pakistani Primary School Children

23 maggio 2026 aggiornato da: Qin jiabi, Central South University

School and Family-Based Multifaceted Intervention Program for Preventing Obesity in Primary School Children in Pakistan: A Cluster Randomized Trial

Childhood obesity is increasing rapidly in Pakistan, but there are no large, high-quality studies testing ways to prevent it in schools. This study aims to find out if a 9-month program involving health education, daily physical activity, parent workshops, and regular feedback via WhatsApp or SMS can reduce the number of primary school children who are overweight or obese.

The study is a cluster randomized controlled trial. A total of 26 primary schools in three cities of Punjab (Lahore, Sahiwal, Bahawalnagar) will be randomly assigned to either the intervention group (13 schools) or the control group (13 schools). Children in grades 3, 4, and 5 (aged 6-12 years) will take part.

In the intervention schools, children will receive 18 health education sessions, daily 45 minutes of physical activity, and monthly weight and height checks. Parents will attend three workshops and receive weekly messages and monthly feedback on their child's progress via WhatsApp or SMS. The control schools will continue their usual activities and receive the intervention materials after the study ends.

The main outcome is the change in the proportion of children who are overweight or obese from the start of the study to 9 months later. Secondary outcomes include changes in BMI z-score, waist circumference, physical activity, eating habits, and parents' knowledge. A follow-up assessment at 12 months will check if any benefits last.

Recruitment of schools and children began on January 8, 2026. This is the first cluster randomized trial of its kind in Pakistan. The results will help inform childhood obesity prevention policies in low- and middle-income countries.

Panoramica dello studio

Descrizione dettagliata

Study Design: Two-phase, prospective, parallel-group, cluster-randomized controlled trial (cRCT) with an embedded mixed-methods process evaluation and longitudinal sustainability follow-up. Phase 1: 9-month primary efficacy trial. Phase 2: sustainability assessment at 12 months from baseline (3 months post-intervention).

Setting: 26 primary schools from three cities in Punjab, Pakistan: Lahore, Sahiwal, and Bahawalnagar. These cities represent the socioeconomic and cultural diversity of Punjab, the most populous province of Pakistan.

Randomization: Schools will be randomized 1:1 to intervention or control using computer-generated sequence, stratified by study site. An independent statistician will perform allocation concealment. Outcome assessors and the statistician will be blinded to group assignment. Participants, parents, and school personnel cannot be blinded due to the behavioral nature of the intervention.

Sample Size: 26 schools (13 intervention, 13 control), approximately 90 children per school, total 2,340 children aged 6-12 years in grades 3-5. Sample size calculation assumed a reduction in overweight/obesity prevalence from 36.7% to 26.7% (10% absolute reduction), 80% power, α=0.05, coefficient of variation k=0.15, and 20% attrition buffer.

Intervention (9 months): Developed using the Social Ecological Model and informed by a systematic review (PROSPERO CRD420251242889). Components include:

Child-focused: 18 biweekly sessions (40 min each) of health education (nutrition, physical activity, screen time reduction) and thematic workshops; daily 45 minutes of moderate-to-vigorous physical activity; monthly BMI measurement by trained staff; weekly self-weighing.

Parent-focused: Three workshops covering health messages, WhatsApp training, and feedback on child's progress; encouragement of 30-60 minutes of daily physical activity outside school.

mHealth component: Weekly automated WhatsApp/SMS messages with health tips and behavior tracking; monthly personalized feedback on child's BMI and behavior change. Tiered system for parents without smartphones (SMS or paper booklets).

Fidelity monitoring: Regular field observations, digital engagement logs, and process evaluation.

Control: Schools continue usual curriculum without any structured obesity prevention program. Routine physical education classes, standard school health checks if available, and no structured nutrition education or family engagement activities. After the 12-month follow-up, control schools receive intervention materials.

Outcomes:

Primary: Change in prevalence of overweight and obesity (WHO BMI-for-age z-score: overweight >+1 SD, obesity >+2 SD) from baseline to 9 months.

Secondary: Change in BMI z-score, waist circumference, body fat percentage, moderate-to-vigorous physical activity (days/week ≥60 min), daily screen time, dietary behaviors (sugar-sweetened beverages, fried foods, fast food), obesity-related knowledge (child), parental knowledge and self-efficacy, physical fitness (rope jumps, sit-ups, standing jump, shuttle run), and sustainability of BMI z-score change at 12 months.

Data Collection: Baseline (month 0), mid-point (month 6), post-intervention (month 9), sustainability follow-up (month 12). Anthropometric measurements (height, weight, waist/hip circumference, body fat percentage), blood pressure, physical fitness tests, and validated child/parent questionnaires.

Statistical Analysis: Intention-to-treat principle using generalized linear mixed models accounting for clustering. Primary outcome: binary prevalence analyzed with binomial distribution and logit link, adjusting for baseline values and stratification factors. Secondary continuous outcomes: mixed models with random intercept for school. Missing data <5% will use maximum likelihood; >5% sensitivity with last-value-carried-forward. Subgroup analyses by region, sex, maternal education, baseline BMI status, and primary caregiver. All tests two-sided α=0.05. Analysis will use SAS 9.4.

Process Evaluation: Concurrent mixed-methods evaluation guided by the EPIS framework to assess fidelity, dose, reach, adaptation, barriers, and facilitators. Quantitative metrics (reach, adoption, implementation fidelity, engagement logs) and qualitative interviews/focus groups with principals, teachers, and parents.

Ethics: Approved by Central South University Institutional Review Board (approval number XYGW-2026-18). Written parental consent and child verbal assent required. Data anonymized and securely stored. Study follows Declaration of Helsinki and local guidelines.

Trial Status: Recruitment began December 8, 2025. Planned primary completion September 8, 2026; study completion December 8, 2026.

Funding/Support: National Natural Science Foundation of China (as per proposal page 1). Sponsor: Central South University.

Tipo di studio

Interventistico

Iscrizione (Stimato)

2340

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Reclutamento
        • Selected Primary Schools in Lahore, Sahiwal, and Bahawalnagar, Punjab, Pakistan
        • Contatto:
        • Contatto:
        • Investigatore principale:
          • Binish Islam

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino

Accetta volontari sani

Descrizione

Inclusion Criteria: Children aged 6-12 years enrolled in grades 3, 4, or 5 of selected primary schools in Lahore, Sahiwal, or Bahawalnagar, Pakistan.

Written informed consent provided by parent or primary caregiver.

Child assent obtained.

Children without any medical conditions that prevent participation in physical activities.

-

Exclusion Criteria: Medical history of heart disease, hypertension, diabetes, tuberculosis, asthma, hepatitis, or nephritis.

Obesity caused by endocrine diseases or side effects of drugs.

Abnormal physical development (e.g., dwarfism, gigantism).

Physical deformity (e.g., severe scoliosis, pectus carinatum, limp, obvious O-leg or X-leg).

Inability to participate in school sport activities.

Weight loss by vomiting or taking drugs during the past three months.

Participation in another obesity prevention or treatment program.

For schools: planned relocation or cancellation within the next two years.

-

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: School and Family-Based Multifaceted Intervention
A 9-month multifaceted program based on the Social Ecological Model. Components: 18 child health education sessions (12 seminars + 6 workshops, 40 min each, biweekly); daily 45 minutes of moderate-to-vigorous physical activity; three parent workshops covering health messages and child progress feedback; monthly BMI monitoring with personalized feedback via WhatsApp/SMS; weekly automated messages for behavior tracking; tiered communication (WhatsApp, SMS, or paper booklets) to ensure all parents can participate. Fidelity monitored through field observations and digital logs.
Behavioral intervention based on the Social Ecological Model, delivered over 9 months. Child components: 18 biweekly sessions (40 min each) of health education (nutrition, physical activity, screen time reduction) and thematic workshops; daily 45 minutes of moderate-to-vigorous physical activity; monthly BMI measurement by trained staff; weekly self-weighing. Parent components: three workshops covering health messages, WhatsApp training, and feedback on child's progress; encouragement of 30-60 minutes daily activity outside school. mHealth: weekly automated WhatsApp/SMS messages with health tips; monthly personalized feedback on child's BMI and behavior change. Tiered system for parents without smartphones (SMS or paper booklets). Fidelity monitoring via field observations and digital logs.
Nessun intervento: Usual Practice (Control)
Schools continue their usual curriculum without any structured obesity prevention program. Routine physical education classes, standard school health checks if available, and no structured nutrition education or family engagement activities related to obesity prevention. After the 12-month follow-up assessment, control schools will be offered the full intervention materials and training

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Prevalence of Overweight and Obesity
Lasso di tempo: Measured at 9 months from baseline
Combined prevalence of overweight and obesity defined according to WHO child growth standards (BMI-for-age z-score). Overweight: z-score > +1 SD; Obesity: z-score > +2 SD.
Measured at 9 months from baseline

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Qin Jiabi, PHD, Kunming Medical University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Collegamenti utili

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

8 dicembre 2025

Completamento primario (Stimato)

8 settembre 2026

Completamento dello studio (Stimato)

8 dicembre 2026

Date di iscrizione allo studio

Primo inviato

23 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

23 maggio 2026

Primo Inserito (Effettivo)

1 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

1 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

23 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

Descrizione del piano IPD

Individual participant data (IPD) that underlie the results reported in the main publication will be available after de-identification. Additional documents such as the study protocol, statistical analysis plan, and informed consent form will also be shared. Data will be available beginning 9 months and ending 36 months after article publication to researchers who provide a methodologically sound proposal. Proposals should be directed to the principal investigator (Qin jiabi, email: qinjiabi123@163.com. To gain access, requestors will need to sign a data access agreement.

Periodo di condivisione IPD

IPD and supporting documents will be available beginning 9 months after publication of the main trial results and ending 36 months after article publication.

Criteri di accesso alla condivisione IPD

De-identified individual participant data and the supporting documents listed above will be made available to researchers who provide a methodologically sound proposal. Data will be shared for the purposes of meta-analysis, secondary research, or re-analysis. Requests should be directed to the principal investigator (Qin jiabi, email: qinjiabi123@163.com). Requestors will be required to sign a data access agreement to ensure data are used only for the agreed purpose and that no attempts are made to re-identify participants.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA
  • ICF

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi